Journal: Research in Pharmaceutical Sciences

Article Title: Aflatoxin G1 exposure altered the expression of BDNF and GFAP, histopathological of brain tissue, and oxidative stress factors in male rats

doi: 10.4103/1735-5362.359434

Figure Lengend Snippet: Nucleotide sequences of primers.

Article Snippet: Primary antibodies were rabbit anti-mouse for GFAP (Biocare, USA, Cas NO: SKU065) and BDNF (Creative Biolabs, USA, Cas NO: CBMAB-AP613LY).

Techniques:

Journal: Research in Pharmaceutical Sciences

Article Title: Aflatoxin G1 exposure altered the expression of BDNF and GFAP, histopathological of brain tissue, and oxidative stress factors in male rats

doi: 10.4103/1735-5362.359434

Figure Lengend Snippet: Quantitative evaluation of (A) GFAP and (B) BDNF gene expression based on GAPDH. Different groups received aflatoxin G1 at 2 mg/kg for 15, 28, and 45 days. Data are presented as mean ± SD. * P < 0.05 and *** P < 0.001 indicate significant differences compared to the control group. GFAP, Glial fibrillary acidic protein; BDNF, brain-derived neurotrophic factors.

Article Snippet: Primary antibodies were rabbit anti-mouse for GFAP (Biocare, USA, Cas NO: SKU065) and BDNF (Creative Biolabs, USA, Cas NO: CBMAB-AP613LY).

Techniques: Gene Expression, Control, Derivative Assay

Journal: Research in Pharmaceutical Sciences

Article Title: Aflatoxin G1 exposure altered the expression of BDNF and GFAP, histopathological of brain tissue, and oxidative stress factors in male rats

doi: 10.4103/1735-5362.359434

Figure Lengend Snippet: (A) Immunohistochemical staining of the cerebral cortex of the rats receiving aflatoxin G1 at 2 mg/kg for 15, 28, and 45 days in order to evaluation of GFAP protein expression. control group; (B) the graph is representing the relative expression of GFAP protein. In the control group, GFAP protein synthesis is seen in the cortical cell line (to a lesser extent), while in the experimental groups of 15, 28, and 45 days, the synthesis of this protein increased over time. In the group receiving aflatoxin G1 for 45 days, protein synthesis increased significantly. ** P < 0.01 and *** P < 0.001 indicate significant differences compared to the control group. GFAP, Glial fibrillary acidic protein.

Article Snippet: Primary antibodies were rabbit anti-mouse for GFAP (Biocare, USA, Cas NO: SKU065) and BDNF (Creative Biolabs, USA, Cas NO: CBMAB-AP613LY).

Techniques: Immunohistochemical staining, Staining, Expressing, Control